Transcriptome Biomarker Validation

Transcriptome Biomarker Validation is a methodological framework within transcriptomic profiling that systematically assesses the reliability, reproducibility, and clinical or biological relevance of transcriptome-derived biomarkers to confirm their utility in diagnosing, prognosing, or monitoring disease states.

36

Publications

4.2K

Citations

473

Authors

198

Institutions

Publications per year

2017–2026

26

Authors

473

  1. MG
    Myron G. Best

    Amsterdam University Medical Centers, Netherlands

    2 publications · 131 citations

    2

    h-index

  2. PK
    Purvesh Khatri

    Stanford University, United States

    2 publications · 120 citations

    2

    h-index

  3. EP
    Edward P. Post

    University of Michigan, United States

    2 publications · 131 citations

    2

    h-index

  4. SG
    Sjors G. J. G. In ‘t Veld

    Amsterdam University Medical Centers, Netherlands

    2 publications · 131 citations

    2

    h-index

  5. BA
    Bakhos A. Tannous

    Massachusetts General Hospital, United States

    2 publications · 131 citations

    2

    h-index

1–5 of 473

Venues

  1. Scientific Reports

    3 publications · 142 citations

    3

    h-index

  2. Oncotarget

    3 publications · 95 citations

    3

    h-index

  3. Genome biology

    1 publications · 49 citations

    1

    h-index

  4. Journal of Clinical Oncology

    1 publications · 296 citations

    1

    h-index

  5. Frontiers in Genetics

    1 publications · 11 citations

    1

    h-index

1–5